ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 933,81
-0,64%
Dow Jones
37 903,29
0,00%
DAX
17 965,06
0,24%
Brent Oil
83,755
0,26%
Bitcoin
58 698,69
0,78%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Pulmonx Corporation (LUNG)

  7. Pulmonx Corporation (LUNG) Actualités

LUNG Pulmonx Corporation

9,5001
1,78 (23,06%)
Avant marché
Dernière mise à jour : 14:34:25
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Pulmonx Corporation LUNG NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
1,78 23,06% 9,5001 14:34:25
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
7,72
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
01/5/202422:05GLOBEPulmonx Reports First Quarter 2024 Financial Results
10/4/202422:05GLOBEPulmonx to Report First Quarter 2024 Financial Results on..
02/4/202422:05GLOBEPulmonx Announces Appointment of Mehul Joshi as Chief..
15/3/202422:00GLOBEPulmonx Announces Inducement Grants under Nasdaq Listing..
08/3/202402:02EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
06/3/202400:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202400:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202400:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202400:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202422:31EDGAR2Form SC 13G - Statement of acquisition of beneficial..
27/2/202422:07EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
27/2/202402:48BWPulmonx meldet Behandlung des ersten Patienten mit dem..
27/2/202402:40BWPulmonx annonce le traitement du premier patient par système..
27/2/202402:39BWPulmonx annuncia il trattamento del primo paziente con il..
27/2/202400:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202414:00BWPulmonx Announces Treatment of the First Patient with the..
22/2/202422:31EDGAR2Form 144 - Report of proposed sale of securities
21/2/202422:08EDGAR2Form 8-K - Current report
21/2/202422:06GLOBEPulmonx Reports Fourth Quarter and Full Year 2023 Financial..
21/2/202422:05EDGAR2Form 8-K - Current report
21/2/202422:05GLOBEPulmonx Announces Retirement of CEO Glen French and..
17/2/202401:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202423:14EDGAR2Form 144 - Report of proposed sale of securities
14/2/202412:17EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/2/202421:42EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
12/2/202423:30EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
07/2/202422:05GLOBEPulmonx to Report Fourth Quarter and Full Year 2023..
31/1/202422:34EDGAR2Form 144 - Report of proposed sale of securities
24/1/202423:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/1/202400:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/1/202422:28EDGAR2Form 144 - Report of proposed sale of securities
18/1/202423:06EDGAR2Form 144 - Report of proposed sale of securities
27/12/202322:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/12/202300:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/12/202322:25EDGAR2Form 144 - Report of proposed sale of securities
21/12/202322:43EDGAR2Form 144 - Report of proposed sale of securities
11/12/202315:00GLOBEThe Honest Company Announces Appointment of Michael Barkley,..
05/12/202323:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202323:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202323:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202323:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/11/202300:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/11/202322:24EDGAR2Form 144 - Report of proposed sale of securities
15/11/202322:05GLOBEPulmonx to Present at the Piper Sandler 35th Annual..
03/11/202321:04EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
31/10/202321:05GLOBEPulmonx to Participate at Upcoming Investor Conferences
30/10/202321:06EDGAR2Form 8-K - Current report
30/10/202321:05GLOBEPulmonx Reports Record Third Quarter 2023 Financial Results
26/10/202300:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/10/202323:10EDGAR2Form 144 - Report of proposed sale of securities

Dernières Valeurs Consultées

NASDAQ
LUNG
Pulmonx
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés